Among the 30 patients with HNSCC, 6 (20.0%) were negative, 12 (40.0%) exhibited low expression, and 12 (40.0%) had high ROR1 expression (Figure 1b,c). This evidence concerns the gene ROR1 and head and neck squamous cell carcinoma.